Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I

Archives of Ophthalmology

Volumn 127, Issue 5, 2009, Pages 622-627

  Löfqvist, Chatarina ^a,e   Hansen Pupp, Ingrid ^b   Andersson, Eva ^a   Holm, Kristina ^c   Smith, Lois E H ^d   Ley, David ^b   Hellström, Ann ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; BIOLOGICAL MARKER; SOMATOMEDIN BINDING PROTEIN 3;

ALGORITHM; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MALE; MONITORING; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROLENTAL FIBROPLASIA; RISK; SCREENING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; BLOOD; LABORATORY DIAGNOSIS; NEWBORN; PHYSIOLOGY; PREDICTION AND FORECASTING; RADIOIMMUNOASSAY; REPRODUCIBILITY; RISK FACTOR;

ALGORITHMS; BIOLOGICAL MARKERS; BIRTH WEIGHT; FALSE POSITIVE REACTIONS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; RETINOPATHY OF PREMATURITY; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 65649119585     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.69     Document Type: Article

References (24)

1. Section on Ophthalmology, American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity [published correction appears in Pediatrics. 2006;118(3):1324]. Pediatrics. 2006;117(2):572-576.
2. Binkhathlan AA, Almahmoud LA, Saleh MJ, Srungeri S. Retinopathy of prematurity in Saudi Arabia: incidence, risk factors, and the applicability of current screening criteria. Br J Ophthalmol. 2008;92(2):167-169.
3. Jandeck C, Kellner U, Lorenz B, Seiberth V; Arbeitsgruppe der Retinologischen Gesellschaft zur Erstellung der Leitlinie zur augenärztlichen Screening-Untersuchung von Frühgeborenen. Guidelines for ophthalmological screening of premature infants in Germany [in German]. Klin Monatsbl Augenheilkd. 2008;225(2):123-130.
4. Wilkinson AR, Haines L, Head K, Fielder AR. UK retinopathy of prematurity guideline. Early Hum Dev. 2008;84(2):71-74.
5. Fielder AR, Gilbert C, Quinn G. Can ROP blindness be eliminated? Biol Neonate. 2005;88(2):98-100.
6. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84(2):77-82.
7. Gilbert C, Fielder A, Gordillo L, et al; International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518-e525.
8. Schiariti V, Matsuba C, Hoube JS, Synnes AR. Severe retinopathy of prematurity and visual outcomes in British Columbia: a 10-year analysis. J Perinatol. 2008;28(8):566-572.
9. Slidsborg C, Olesen HB, Jensen PK, et al. Treatment for retinopathy of prematurity in Denmark in a ten-year period (1996-2005): is the incidence increasing? Pediatrics. 2008;121(1):97-105.
10. Löfqvist C, Andersson E, Sigurdsson J, et al. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity [published correction appears in Arch Ophthalmol. 2007;125(3):426]. Arch Ophthalmol. 2006;124(12):1711-1718.
11. Bergman E, Kieler H, Petzold MG, Sonesson C, Axelsson O. Symphysis-fundus measurements for detection of small for gestational age pregnancies. Acta Obstet Gynecol Scand. 2006;85(4):407-412. (Pubitemid 43879188)
12. Andersson E, Bock D, Frisén M. Modeling influenza incidence for the purpose of on-line monitoring. Stat Methods Med Res. 2008;17(4):421-438.
13. Bock D, Andersson E, Frisén M. Statistical surveillance of epidemics: peak detection of influenza in Sweden. Biom J. 2008;50(1):71-85.
14. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684-1694.
15. Marsál K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85(7):843-848. (Pubitemid 26267023)
16. Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regul. 1994;4(suppl 1):11-19.
17. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991-999.
18. Frisén M. Evaluations of methods for statistical surveillance. Stat Med. 1992;11(11):1489-1502.
19. Clarke WN, Hodges E, Noel LP, Roberts D, Coneys M. The oculocardiac reflex during ophthalmoscopy in premature infants. Am J Ophthalmol. 1985;99(6):649-651. (Pubitemid 15059935)
20. Kleberg A, Warren I, Norman E, et al. Lower stress responses after Newborn Individualized Developmental Care and Assessment Program care during eye screening examinations for retinopathy of prematurity: a randomized study. Pediatrics. 2008;121(5):e1267-e1278.
21. Laws DE, Morton C, Weindling M, Clark D. Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol. 1996;80(5):425-428. (Pubitemid 26158275)
22. Clemmons DR. IGF-I assays: current assay methodologies and their limitations. Pituitary. 2007;10(2):121-128. (Pubitemid 46863726)
23. Hellström A, Engström E, Hård AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003;112(5):1016-1020. (Pubitemid 37339551)
24. Villegas Becerril E, Gonzalez Fernández R, Fernández Molina F, Gallardo Galera JM. Growth factor levels and ROP. Ophthalmology. 2005;112(12):2238.